Millie
your market intelligence analyst
Search Results
300 results
Your search is now limited to «Ovarian Cancer» expert search.
GlobeNewswire 07/18/2019 08:00
The collaboration will focus on using Helomics’ artificial intelligence (AI) platform (D-CHIP™) to analyze the genomic and drug response profiles of women with ovarian cancer to determine predictive value in terms of response/non-response to therapy.
More from GlobeNewswire:
ClinicalTrials.gov 07/18/2019 07:48
It is known that ovarian cancers have mutations (changes in genetic material) that are specific to an individual patient and tumor.
More from ClinicalTrials.gov:
Onclive 07/17/2019 15:46
Matthew Powell, MD Single-agent immunotherapy has elicited minimal responses in patients with ovarian cancer, but the preclinical rationale for combinations with chemotherapy, antivascular therapy, and PARP inhibitors is strong and worthy of further pursuit, said Matthew Powell, MD.
More from Onclive:
Ovarian Cancer News Today 07/17/2019 11:25
A blood test successfully identified ovarian cancer from circulating cells, and may enable this cancer to be detected early and prior to surgery, results of the first phase of a clinical verification study show.
More from Ovarian Cancer News Today:
BioNewsFeeds 07/17/2019 11:25
A blood test successfully identified ovarian cancer from circulating cells, and may enable this cancer to be detected early and prior to surgery, results of the first phase of a clinical verification study show.
More from BioNewsFeeds:
GSK’s Zejula meets primary endpoint in phase 3 ovarian cancer trial.
More from Pharmaceutical Business Review:
PubMed News (NIH) 07/17/2019
Contributors : Nouri Neamati ; Tiangong Lu ; Armand Bankhead Series Type : Expression profiling by high throughput sequencing Organism : Homo sapiens. Inhibiting STAT3 signaling reduces tumor progression, metastases and chemoresistance, however the precise molecular mechanism has not been fully delineated in ovarian cancer.
More from PubMed News (NIH):
Business Wire 07/16/2019 08:00
... study of 993 patients with 245 malignancies shows that Vermillion’s second generation multivariate index assay, Overa® (MIA2G), had superior sensitivity to the current standards of care, Risk of Malignancy Algorithm (ROMA) and CA125, in detecting ovarian cancer, and the lowest false-negative rate in correctly characterizing ovarian malignancy risk.
More from Business Wire:
Targeted Oncology 07/15/2019 14:34
Patients were required to have high-grade predominantly serous or endometrioid ovarian cancer, fallopian tube cancer, or primary peritoneal cancer.
More from Targeted Oncology:
ETHealthWorld (India) 07/15/2019 05:39
GSK's ovarian cancer treatment meets main goal in late-stage study, Health News, ET HealthWorld.
More from ETHealthWorld (India):
Indeed, SCGB2A1 expression is associated with favorable prognosis in endometrial carcinomas and longer recurrence-free survival in ovarian carcinomas (41, 48.
More from Clinical Cancer Research - Recent Issues (abstracts):

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications